Moreover, the population of CD4+CD25+Foxp3+ Tregs and Gr1+CD11b+ MDSCs was not increased by RT plus iPSC-based cancer vaccines, indicating that this therapeutic strategy might not induce Treg-mediated suppression of TAA-reactive T cells. The gene discussed is FOXP3; the disease is cancer.